Dr. Daniel Cameron

Hydroxychloroquine and Azithromycin for COVID-19: Early Evidence Welcome to another Inside Lyme Podcast. In this episode, I review the early evidence evaluating hydroxychloroquine and azithromycin as potential treatments for COVID-19. Update: This article was written early in the COVID-19 pandemic when clinicians were urgently evaluating existing medications. Since then, research efforts have focused largely on […]

Dr. Cameron feels that the best way to get to know COVID-19 is through reviewing actual cases. In this Podcast episode, he will be discussing a 73-year-old resident of a skilled nursing facility who died from COVID-19. McMichael and colleagues discussed this case in the New England Journal of Medicine in 2020. As of March

34 residents of a single skilled nursing facility died from COVID-19. An Inside Lyme Podcast. By Dr. Daniel Cameron You may be wondering why I am discussing COVID-19 during an Inside Lyme podcast. I am concerned for my children, grandchildren, and my patients. My mother is 90 years old and currently on lockdown in a

COVID-19 Podcast: Evidence supporting hydroxychloroquine and azithromycin for COVID-19. Dr. Cameron feels that the best way to get to know COVID-19 is through reviewing actual cases. In this Podcast episode, he will discuss the evidence supporting hydroxychloroquine and azithromycin for COVID-19. Update: Doctors have shifted their focus on other treatments and vaccine instead of hydroxychloroquine

COVID-19 Podcast: Transmission from patient to health care worker. Dr. Cameron feels that the best way to get to know COVID-19 is through reviewing actual cases. In this Podcast episode, he will discuss the risk for patient to health care worker and patient-to-patient transmission of CVID-19 Wang and colleagues first discussed this case in the

COVID-19 Podcast: Fecal transmission of COVID-19 in children? You may be wondering why I am discussing COVID-19 during an Inside Lyme podcast. I am concerned for my children, grandchildren, and my patients. I would like to share my understanding of COVID-19 through my eyes as a clinical epidemiologist. I was surprised to run across the